Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Lineage Enters Into Option and License Agreement With Eterna Therapeutics to Develop Hypoimmune Pluripotent Cell Lines for Multiple Neurology Indications
Lineage Cell Therapeutics, a clinical-stage biotechnology company developing allogeneic cell therapies to replace and restore […]
ValGenesis and Enterey Partner to Deliver a Better Consulting Experience for Life Sciences Companies Going Digital
ValGenesis, the market leader in enterprise Validation Lifecycle Management Systems (VLMS), and Enterey, a specialist […]
Vysioneer Announces Data Sharing Agreement with Pfizer to Augment Oncology Clinical Trials with Artificial Intelligence
Vysioneer, a pioneer in AI for Oncology, today announced a data-sharing agreement with Pfizer, a […]
Maternova and MedMira Enter Distribution Agreement to Market Rapid Diagnostics for HIV, Syphilis and Hepatitis
Maternova, accelerating advances in maternal and infant health through innovative, accessible solutions, and MedMira, a […]
TheraVet Signs an International Distribution Agreement for BIOCERA-VET Covering 24 Countries
TheraVet, a pioneering company in the management of osteoarticular diseases in pets, announces the signing […]
Actinium Announces Positive Full Data Results From the Pivotal Phase 3 SIERRA Trial in Patients with Active, Relapsed or Refractory Acute Myeloid Leukemia
Actinium Pharmaceuticals, a leader in the development of targeted radiotherapies, today announced positive results for […]
Terumo Blood and Cell Technologies' IMUGARD Platelet Pooling Set Cleared by FDA
Today, Terumo Blood and Cell Technologies have announced US Food and Drug Administration (FDA) clearance […]
Aqilion announces Pre-clinical Licensing and Strategic Research Collaboration Agreement with Merck
Aqilion today announced an exclusive license and strategic research collaboration with Merck to discover, develop […]
LIfT BioSciences and Minaris Regenerative Medicine Enter into a Development and Manufacturing Partnership
LIfT BioSciences, a pioneering pre-clinical stage company moving into first-in-human trials with an allogeneic neutrophil […]
Charles River and Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration
Charles River Laboratories International and Purespring Therapeutics, a pioneering gene therapy company focused on transforming […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more